| Mark J Lenig, | |
|
27 David Post Rd, Annandale, NJ 08801-2009 | |
| (908) 455-6083 | |
| Not Available |
| Full Name | Mark J Lenig |
|---|---|
| Gender | Male |
| Speciality | Counselor |
| Location | 27 David Post Rd, Annandale, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003526716 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark J Lenig, 27 David Post Rd, Annandale, NJ 08801-2009 Ph: (908) 455-6083 | Mark J Lenig, 27 David Post Rd, Annandale, NJ 08801-2009 Ph: (908) 455-6083 |
News Archive
ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its new Octet QK(e) instrumentation system. The new system, the next generation of the company's initial eight-channel Octet QK instrument, provides significantly increased sensitivity, enabling analysis of small proteins and peptides. Additionally, the Octet QK(e) system enables biosensors to be re-racked, for increased workflow flexibility and cost savings.
Stroke is the epidemic disease of the twenty-first century and the second most frequent cause of death in 2011, accounting for 11% of all deaths worldwide. Stroke is also the second most important cause of permanent disability and...
Unigene Laboratories, Inc. announced today that Novartis has released information on the first of two studies on oral calcitonin for the treatment of osteoarthritis conducted by its license partner Nordic Bioscience. The recently completed Study 2301, which assesses the safety and efficacy of oral calcitonin in the treatment of knee osteoarthritis, had three co-primary endpoints.
Raptor Pharmaceutical Corp., announced it has entered into a securities purchase agreement in connection with a private placement, or PIPE financing. Upon the closing of the PIPE financing, Raptor will receive gross proceeds of approximately $15 million resulting from the sale of 4,897,614 units at a purchase price of $3.075 per unit.
› Verified 5 days ago
Mr. Mark Hodkinson, MA, LCADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 2 Cheryle Way, Annandale, NJ 08801 Phone: 908-578-4390 | |
Samantha Marie Keyes, MA, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1465 Nj-31 S, Beaver Brook Concourse, Suite 7, Annandale, NJ 08801 Phone: 908-237-2577 Fax: 908-894-5309 |